SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-18-000097
Filing Date
2018-11-07
Accepted
2018-11-07 16:05:42
Documents
47
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20180930.htm   iXBRL 10-Q 947338
2 exhibit31-1q32018.htm EX-31.1 9835
3 exhibit31-2q32018.htm EX-31.2 9972
4 exhibit32-1q32018.htm EX-32.1 4812
5 exhibit32-2q32018.htm EX-32.2 4635
  Complete submission text file 0001125345-18-000097.txt   4515823

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20180930.xsd EX-101.SCH 32527
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20180930_cal.xml EX-101.CAL 46484
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20180930_def.xml EX-101.DEF 173067
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20180930_lab.xml EX-101.LAB 359158
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20180930_pre.xml EX-101.PRE 263055
11 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20180930_htm.xml XML 836999
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 181166297
SIC: 2834 Pharmaceutical Preparations